NCT05983042View on ClinicalTrials.gov

Effect of CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions

Healthy Volunteers

Interventions

GENETIC

Ibuprofen

Ibuprofen 400mg three times a day for three days

Trial Locations (1)

46000

Ammarah Amjad, Rawalpindi

All Listed Sponsors

lead

Riphah International University

OTHER